Kyle Landrum
Equibles does not estimate personal net worth.
Get an email with a short summary when Trulieve Cannabis Corp. publishes a filing, an earnings call transcript or a press release.
Get TRLV alertsAbout Kyle Landrum
The proxy statement of Trulieve Cannabis Corp. reports total compensation of $1,287,392 for Kyle Landrum in fiscal 2025, including a base salary of $350,000. Disclosed compensation is on record for 4 fiscal years. Trulieve Cannabis Corp. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Trulieve Cannabis Corp. includes Kim Rivers (CEO and Board Member), Jan Reese (CFO and Chief Accounting Officer), Ryan Blust (CFO) and 7 others.
Affiliation history
-
Trulieve Cannabis Corp. (TRLV)
Proxy statement
CurrentStart not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Trulieve Cannabis Corp.
- Kim Rivers CEO, Board Member
- Jan Reese CFO, Chief Accounting Officer
- Ryan Blust CFO
- Timothy Mullany CFO
- Wes Getman CFO
- Marie Zhang COO
- Nilyum Jhala CTO
- Brett Walsh Chief Accounting Officer
- Jane Morreau Board Member
- Matthew Foulston Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $350,000 | $1,287,392 |
| 2024 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $350,000 | $1,433,792 |
| 2023 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer Represents the grant date fair value of restricted stock unit awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718. Represents the grant date fair value of option awards granted in fiscal years 2025, 2024, and 2023 in accordance with ASC Topic 718, which includes the use of the "simplified" method due to our limited trading history. Represents non-equity incentive plan compensation for each fiscal year based on achievement of qualitative and quantitative performance objectives for each fiscal year as determined by the Compensation and Human Resources Committee. 2025 and 2024 include employer paid portions of premiums for life, dental, and vision insurance, while 2024 also includes 401k match contributions and a health reimbursement arrangement (HRA). 2023 includes employer paid portions of premiums for certain benefits. Mr. Reese's employment with the Company began on September 8, 2025. Mr. Blust was appointed interim CFO effective March 6, 2025, and relinquished his duties upon the appointment of Mr. Reese, effective September 8, 2025. Mr. Getman resigned as CFO effective March 6, 2025. | $315,000 | $1,004,378 |
| 2022 | Trulieve Cannabis Corp. (TRLV) | Chief Production Officer | $300,000 | $1,259,861 |
Recent activity
No call appearances or filed executive changes recorded yet.